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Abstract: Pain is a major symptom in many medical conditions, and often interferes 
significantly with a person’s quality of life. Although a priority topic in medical research 
for many years, there are still few analgesic drugs approved for clinical use. One reason is 
the lack of appropriate animal models that faithfully represent relevant hallmarks 
associated with human pain. Here we propose zebrafish (Danio rerio) as a novel short-term 
behavioral model of nociception, and analyse its sensitivity and robustness. Firstly, we 
injected two different doses of acetic acid as the noxious stimulus. We studied individual 
locomotor responses of fish to a threshold level of nociception using two recording 
systems: a video tracking system and an electric biosensor (the MOBS system). We 
showed that an injection dose of 10% acetic acid resulted in a change in behavior that 
could be used to study nociception. Secondly, we validated our behavioral model by 
investigating the effect of the analgesic morphine. In time-course studies, first we looked at 
the dose-response relationship of morphine and then tested whether the effect of morphine 
could be modulated by naloxone, an opioid antagonist. Our results suggest that a change in 
behavioral responses of zebrafish to acetic acid is a reasonable model to test analgesics. 
The response scales with stimulus intensity, is attenuated by morphine, and the analgesic 
effect of morphine is blocked with naloxone. The change in behavior of zebrafish 
associated with the noxious stimulus can be monitored with an electric biosensor that 
measures changes in water impedance. 
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1. Introduction 
Pain research and its translation into improved diagnosis and therapy both have a high priority 
because of the increasing incidence of pain disorders with ageing [1,2]. In spite of this, progress in 
neuropharmacology and therapeutics worldwide is largely stalled, with only a small number of 
substances qualifying for clinical use [3]. This is in part due to the lack of appropriate animal models 
to mimic these conditions and to assess the validity of candidate drugs. 
Mammalian models are commonly used to develop safer and more effective pain treatments for 
patients. However, this is a controversial issue from an ethical point of view and has encouraged the 
development of alternative non-mammalian models. There are reports using fish, amphibians, reptiles 
or birds to understand the mechanisms of opioid analgesia and also to test the selectivity of analgesic 
drugs [4,5]. Fish possess the necessary sensory components to detect a noxious stimulus and also have 
brain areas similar to those of higher vertebrates that respond to painful stimuli [6], although some 
argue that the responses are simply reflexive [7]. The neuronal activity detected in fish brain centers 
such as the spine, cerebellum, tectum and telencephalon also suggests the possibility of pain perception 
in fish in which the dorsal telencephalon (similar to the cortex in mammals) may mediate the 
coordination of the pain information [8,9]. As a result of these observations, teleost fish have been 
used as models for pain and analgesia research [10,12-15]. However, only few fish species have been 
used to test the efficacy of opioids and non-opioids [12,14-16]. 
We selected zebrafish (Danio rerio) as a test species because its nervous system shares many 
fundamental similarities with other vertebrates, including the opioid system [17,18]. We used zebrafish 
to develop an acute behavioral nociceptive test that monitors individual swimming responses to a 
noxious chemical stimulus. On the basis of an electronic biosensor device (MOBS), locomotor 
responses to acetic acid were recorded, a noxious agent that reduces activity of zebrafish [13]. These 
nociceptive responses to acetic acid are the basis of our model and we investigated in time-course 
studies its applicability and robustness with treatments of an analgesic drug (morphine) and an opioid 
receptor competitive antagonist (naloxone). First we tested two different doses of acetic acid to 
estimate the optimal dose. As “optimal” we defined a dose that reduced fish activity in a stable manner 
long enough to do an experiment, but was not an overdose resulting in freezing behavior or death. A 
strong difference between control and nociceptive fish responses is also important from a statistical 
point of view, as it supports the detection of significant changes to nociceptive activity (e.g., in 
response to further drug treatments), especially as behavioral endpoints are typically exhibit high 
variance. Our dose-finding study was performed with two recording systems, an electric biosensor (the 
MOBS system) and by video tracking. The latter was used to confirm the results of the automatic 
system, which then was used as standard recording system in subsequent studies. 
Next, we investigated whether our system was able to identify anti-nociceptive responses caused by 
two doses of morphine. Although the primary aim of our study was to detect changes from the 
nociceptive response baseline, we also were interested whether dose-response pattern could be 
detected. In the last study we tested whether the effect of morphine could be attenuated by naloxone, a 
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drug that is commonly used to counter the effects of opiate overdoses. In our study, zebrafish were 
exposed to three different agents, an experimental situation that we considered very demanding of our 
test system. 
2. Material and Methods 
2.1. Chemicals 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). Solutions of acetic acid 
(5 and 10%) were dissolved in deionised water and morphine and naloxone solutions in sterile saline 
(0.9% NaCl). Buffered tricaine methanesulfonate (MS222) was used to anesthetize the fish. 
2.2. Test Animals 
The zebrafish (D. rerio Hamilton 1822) strain used for this work was the AB line (Zebrafish 
Facility, IMM, Portugal). Animals were maintained under standard conditions and experiments were 
approved by the Institutional Animal Care and Use Committee. 
2.3. Behavioral Assay 
2.3.1. General Protocol 
Before the experiments, small groups of male fish (10-15 animals, body weight 0.5 ± 1g) were 
acclimatized to the experimental testing conditions (temperature 22 °C ± 1 °C, 10 h:12 h light-dark 
cycle) in 17 liter glass aquaria under static conditions and for a minimum of one week. Food was not 
provided 24 h before or during the experiments. On the day of experiments, either the treated or 
control groups of fish were placed individually in the test chambers supplied with oxygenated tap 
water (22 °C ± 1 °C). Ungrouped fish were acclimated to the test chambers for 30 min and then 
individual baseline responses (pre-treatment) were monitored for one hour between 10 and 12 a.m. 
Each fish was individually anesthetized using tricaine (50 mg/L) and then was injected with the test 
substance(s). During the injection they were in a medium-to deep-plane level of anaesthesia and had 
lost their reflex responses and muscular control. Afterwards they returned to their original test 
chambers and allowed 30 min to recover from the anaesthesia. Individual fish swimming responses 
(post-treatment) were then recorded for 80 min, i.e., 110 min after the injection. We recorded 
individual fish activity from four fish per day, as we considered this sample size as best to minimize 
the delays due to the injection scheme in relation to the simultaneous recording of all sample fish in the 
MOBS system. After behavioral recording, fish were sacrificed humanely by concussion followed by 
severing the spinal cord. The behavioral experiments always were performed by the same 
experimenter. 
2.3.2. MOBS System 
A detailed description of this equipment is reported elsewhere [11]. Briefly, the system consists of a 
hardware device, a set of four experimental test chambers (cylindrical chambers, 6 cm in diameter, 10 cm 
long) and signal processing software running on an external computer. The device injects weak analog 
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electrical signals into the water of the test chambers through a pair of non-invasive stainless steel 
electrodes. The shape and spectrum of these signals are generated by the software in the digital domain. 
The response is measured as a change in impedance of the water column received by another pair of  
non-invasive stainless steel electrodes associated with movements of the fish. These recorded signals are 
amplified and converted back into the digital domain at 48 kHz, filtered, demodulated and down-sampled 
to 100 Hz. Upon processing, the system provides a signal in the frequency band of 0.2 Hz to 40 Hz that is 
correlated with the fish activity. In preliminary studies we adjusted the software of the MOBS system 
to a specific locomotion behavior of zebrafish, with series of bursts in the domain of MOBS 
corresponding to the tail-flip activity of zebrafish. Thus the outcomes from MOBS reflect the number 
of tail-flips per minute per individual fish. 
2.3.3. Video Recording System 
Individual fish were placed in a small tank (9 cm × 8 cm) and their swimming behavior recorded 
with a video camera positioned over the tank. Online records were acquired in movies of 1 min length 
(600 frames), saved on the computer and later analyzed for speed activity (mm/sec) using the software 
Image Pro-Plus®. Speed was calculated as the change in position in two dimensions. 
During the experiments, the pre-treatment behavior of individual fish was recorded for 15 min before 
anesthesia. After a recovery period of 30 min, post-treatment behavior was recording every 10 min  
(10 movies of 600 frames each) at intervals of 30 min after recovery (three sections of records were 
done). The experimenter was not visible by the fish during recording. 
2.4. Experimental Studies 
2.4.1. Study 1—Zebrafish Behavioral Model of Nociception 
The purpose of this study was to identify an effective dose of acetic acid without losing fish due to 
freezing behavior or mortality. Two doses of acetic acid (5% and 10%) were selected on the basis of 
literature data [13] and tested using the MOBS system. The higher dose was favored as default 
nociceptive dose for the final model under the prerequisite of: (1) significantly lower fish activity 
compared with the responses to 5% acetic acid, (2) stable response over the recording period, and (3) 
no higher loss of fish than for the controls. 
The acetic acid was carefully injected with a total volume of 5 µL per 0.5 g fish (5%, n = 6 or 10%, 
n = 8) into the top and bottom frontal lips of fish using a gastight syringe and a 30-gauge needle 
(Hamilton, Reno, NV, USA). The control group (n = 14) was injected with a sterile saline solution. 
The study with the MOBS system consisted of six experiments, each including two controls and both 
acetic acid treatments, and one experiment with two controls and two 10% acetic acid treatments. For 
the video tracking system, the injection procedure was the same, and again we tested four fish per day, 
with 8 experimental runs with two controls and two 10% acetic acid treatments, and a final run with 
saline only treatments. The protocol of the injection procedure is shown in Figure 1. 
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Figure 1. Experimental study design. 
 
2.4.2. Study 2—Effect of Morphine on Zebrafish Nociceptive Behavior 
The aim of study 2 was to test the efficacy of morphine to induce anti-nociceptive behavior in the 
zebrafish model. Fish were first treated with two morphine doses (3 and 6 mg/kg) and afterwards 
stimulated with acetic acid using the same procedure as the first study. The two morphine doses were 
selected on the bases of literature data [19]. In addition, we also tested a control group of fish, treated 
with a saline solution instead of morphine. All three treatments were administered intramuscularly into 
anesthetized fish, with morphine in a total volume of 3.0 µL per 0.5 g fish by RN gastight syringe 
(Hamilton). Two control treatment groups were tested, the first with morphine only, and the second 
with saline only, i.e., fish from both these control groups were not exposed to acetic acid. The dosing 
schemes for this as well other all studies are shown in Table 1. 
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Table 1. Dosing schemes used with the automatic recording system (MOBS).  
* N = number of fish used for data analysis, in brackets number tested. 
 Injection 
 Intramuscular   Lip N* 
Study 1 ---  5 µL saline solution 12 (14) 
 ---  5 µL acetic acid 5% 6 (6) 
 ---  5 µL acetic acid 10% 8 (8) 
Study 2 3 µL saline solution + 5 µL acetic acid 10% 10 (10) 
 3 µL morphine 3mg/kg + 5 µL acetic acid 10% 9 (10) 
 3 µL morphine 6mg/kg + 5 µL acetic acid 10% 8 (10) 
 3 µL morphine 3mg/kg + 5 µL saline solution 7 (8) 
 3 µL saline solution + 5 µL saline solution 8 (8) 
Study 3 3 µL morphine 6mg/kg
+ 3 µL naloxone 6mg/kg
+ 5 µL acetic acid 10% 11 (12) 
 3 µL morphine 6mg/kg
+ 3 µL saline solution
+ 5 µL acetic acid 10% 9 (10) 
2.4.3. Study 3—Modulation of the Analgesic Effect of Morphine with Naloxone 
The purpose of study 3 was to investigate whether anti-nociceptive behavior induced by morphine 
could be altered by naloxone, an antagonist of mu-opioid receptors. Two treatment groups were tested, 
with fish receiving either 6 mg/kg morphine together with saline solution or 6 mg/kg morphine 
together with 6 mg/kg naloxone. Morphine and naloxone (or saline) were co-injected intramuscularly 
(6 mg/kg: 6 mg/kg, in a total volume of 6 µL) in pre-anesthetized fish by using a RN gastight syringe 
(Hamilton). Fish from both groups were later treated with 10% acetic acid injections to the lips. The 
protocol of the injection procedure is illustrated in Figure 1, and the dosing scheme together with 
numbers of fish tested is shown in Table 1. 
2.5. Data Analysis 
Behavioral data were normalized on a fish-by-fish basis to the medians of their individual  
pre-treatment values and expressed as a percentage, so all results describe changes relative to the 
median of pre-treatment values. Pre-treatment values should be a representative description of the 
individual fish activity, but fish tended to be more active at the beginning of the 30 min recording 
period. Thus, for each fish we used the pretreatment values when they became stable (see Figure 2). 
All data from the same study and treatment from different days were pooled for further statistical data 
analysis. For graphical presentation, data were expressed as the 20% Winsorized mean with its 
standard error [20].This estimator is less sensitive to outliers as it uses the 10% highest and 10% 
lowest value to replace the most extreme values. The effect of treatments on the changes of zebrafish 
behaviors across the recording sessions was analyzed using a nonparametric mixed-effect model for 
longitudinal data [21]. This model is more robust against extreme values that occur when recording 
behavioral activity. The level of statistical significance was set to p < 0.05. All statistical analysis was 
performed using the SAS statistical software (SAS Institute Inc., Cary, NC, USA). 
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3. Results 
Due to the experimental setup only four fish per day were tested and data from different test days 
were used. As a consequence we cannot exclude the possibility that the variation in our data might 
have increased (inter-day variation), but we found no indications of a systematic trend. The fish 
numbers per treatment are shown in Table 1. 
3.1. Pre-Treatment Behavior 
We observed large differences in activity level between untreated individual fish that were 
independent of the length of the recording time. This prevented the data pooling of the absolute 
measurements. Therefore we used relative changes (ratio) between the individual post-treatment values 
and the pre-treatment activity. Statistically, a ratio is very sensitive to small errors in the estimation of 
the pre-treatment median, which meant that the individual fish behavior must be representative and 
stable. Figure 2 summarizes the pre-treatment activity from 26 fish over a 60 minute period. Individual 
measurements from MOBS were normalized to the median of values from the last 20 min because the 
average fish activity was most stable in this time period.  
Figure 2. Pre-treatment activity of zebrafish recorded by the MOBS system. Data have 
been normalized to the median of readings from the last 25 min and are shown as 
Winsorized mean ± standard error (N = 27). Values when activity had stabilized were used 
to normalize the data for each fish. 
 
Earlier a clear negative trend is visible, with fish reducing their activity by an average of about 
20%. Also the error bars are 6 times larger at beginning of the recording than in the last 20 min. These 
observations strongly imply that the recording of pre-treatment behavior should be performed over a 
sufficiently long time period in order to avoid a biased estimation of treatment responses. 
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3.2. Zebrafish Behavioral Model of Nociception 
The time-course changes in zebrafish activity are shown in Figure 3A after injection of two doses of 
acetic acid or saline into the lips. They were recorded by the MOBS system for 80 min after a recovery 
period of 30 min after injection. Both treatments resulted in a significant decrease in activity  
(p < 0.01), and the three treatments (saline control, 5%, 10%) all differed significantly from one 
another (p < 0.01). Saline control fish were less active than before treatment (black symbols, Figure 
3A) but this decrease was not statistically significant. Fish treated with 10% acetic acid showed a 
robust and stable decrease in fish activity for 60 min after injection. Therefore, we used 10% acetic 
acid injection as the noxious stimulus in all subsequent studies. 
In separate trials we measured fish activity using a video camera (Figure 3B). Similar to that 
recorded with the MOBS system, the 10% acid injection resulted in a significant decrease in fish 
activity. In these trials activity continued to decrease throughout the observation period and the slopes 
of the decrease in activity with time differed between saline control and 10% acetic acid injection  
(p < 0.001). The saline controls recovered only to 80% from their pre-treatment activity, whereas the 
acid treated fish showed at the end decreased activities that were comparable to those recorded  
by MOBS. 
Figure 3. Time-course changes in zebrafish activity after injection of 10% acetic acid 
(red), 5% acetic acid (green) and control saline solution (black). Fish activity was recorded 
using the MOBS system (A) and by video analysis (B). All values are normalized to the 
median of pre-treatment activity (100%). Fish activities for periods of 15 min and 10 min 
(MOBS system (A) and video recording (B), respectively) are shown as Winsorized  
mean ± standard error, connected with a solid line. Recorded time periods are highlighted 
as grey bars above the time scale. 
 
3.3. Effect of Morphine on Zebrafish Nociceptive Behavior 
Morphine injected prior to the acid injection attenuated the decrease in activity associated with the 
noxious stimulus (Figure 4). Both morphine treatments resulted in a significant increased activity 
compared with the acid treated fish, but not differ significantly from one another (p = 0.12). However, 
this is largely because there was no difference between doses during the first 60 min of the recording 
period. The difference between doses was significant considering only the last 60 min of the recording 
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period. Saline control fish responded with nearly the same activity as measured before treatment. 
Compared with the outcomes from the first study, the variation in all treatment groups was greater, 
possibly reflecting a higher degree of individual behavior pattern to the more complex injection 
procedure. However, the fish responses to the noxious acid stimulus were in good agreement between 
both studies (Figure 5); there were no statistical significant differences between them. Our results 
show that the model has good reproducibility and is robust. Morphine alone (i.e., in the absence of any 
noxious stimulus) resulted in a small decrease in fish activity but activity levels did not differ from 
saline controls (data not shown). That is, morphine in and of itself, did not have a significant effect. 
Figure 4. Time-course changes in zebrafish activity associated with a noxious stimulus 
(10% acetic acid lip injection) to intramuscular treatments with 0 mg/kg morphine (red),  
3 mg/kg morphine (light green) and 6 mg/kg morphine (dark green). In addition, a group of 
control fish with no noxious stimulus was treated with saline solution (black). All values 
were recorded using the MOBS system and are normalized to the median of pre-treatment 
activity (100%). Fish activities for periods of 15 min are shown as Winsorized  
mean ± standard error, connected by a solid line. 
 
3.4. Modulation of the Analgesic Morphine Effect through Naloxone 
The decrease in fish activity caused by the injection of 10% acetic acid was attenuated by a prior 
injection of 6 mg/kg morphine (green symbols, Figure 6), resulting in a stable activity level of about 
70% at the end of the recording period. Compared with fish from study 2 that were treated 
intramuscularly only with morphine, these results were very similar (Figure 5, black and gray 
symbols), indicating that the saline solution had no significant impact on the outcomes. The 
attenuation of the decrease in activity was blocked when naloxone was injected at the same time as the 
morphine (red symbols, Figure 6): the treatments of morphine with and without naloxone were 
significantly different at all time periods after the acid injection. The average activity from the 
naloxone and morphine treated fish were only slightly higher than from fish that were treated by only 
acid lip injection (red symbols, Figure 3A), suggesting that naloxone counteracted the effects of 
morphine. 
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Figure 5. Impact of intramuscular saline solution on the time-course changes in zebrafish 
activity. Fish were treated with 10% acetic acid injection alone (dark red), in combination 
with 3µL saline solution (intramuscular injection, light red), in combination with 6 mg/kg 
morphine (intramuscular injection, gray), and in combination with 6 mg/kg morphine and 
3µL saline solution (black). Treatments are from different studies, all values were recorded 
using the MOBS system and are normalized to the median of pre-treatment activity 
(100%). Fish activities for periods of 15 min are shown as Winsorized  
mean ± standard error, connected with a solid line. 
 
Figure 6. Time-course changes in zebrafish activity to 0 mg/kg naloxone (green) and  
6 mg/kg naloxone (red). All fish were treated with a noxious stimulus (10% acetic acid 
injection) that was attenuated by 6 mg/kg morphine (intramuscular injection). All values 
were recorded using the MOBS system and are normalized to the median of pre-treatment 
activity (100%). Fish activities for periods of 15 min are shown as Winsorized  
mean ± standard error, connected by a solid line. 
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4. Discussion 
Current knowledge about nociception in fish is limited and our present study provides relevant data 
about the capacity of zebrafish for nociception and the efficacy of morphine as an analgesic and 
naloxone as antagonistic substance. Our main goal was to test if the locomotor response to a noxious 
chemical stimulus in zebrafish is a sensitive and robust model that can be used to evaluate analgesics. 
In particular, does the response scale with the intensity of the stimulus? Does morphine attenuate the 
response to the noxious stimulus in a dose dependent manner? Is the effect of morphine blocked with 
naloxone? In addition we were interested in assessing the value of an automated monitoring system 
(MOBS) for the zebrafish model by comparing it with traditional video techniques. 
4.1. Zebrafish Behavioral Responses to a Chemical Stimulus 
The utility of non-mammalian models in the study of pain has been presented before, especially by 
Stevens [4]. The particular advantages of using zebrafish as a model in chemical screens have been 
reviewed by Zon and colleagues who argued that there is no better vertebrate suited to high-throughput 
phenotyping [22,23]. The main advantages are their cost-effectiveness, large number of offspring (up 
to 300 per female) and abundance of molecular and genomic tools. 
One challenge in pain studies in a novel animal model is the choice of the nociceptive stimulus. The 
many advantages and disadvantages of chemical, thermal, force or electrical stressors have been 
reviewed by Le Bars et al. [24]. There is convincing evidence that fish possess nociceptors that react in 
a fashion similar to those in mammals [6,25,26]. Moreover, there is some evidence regarding the 
pathway from peripheral nociceptors to the brain [8,9]. Recently acetic acid has been used to stimulate 
peripheral nociceptors in fish [25,27] and in one study in zebrafish. Reilly et al. [13] reported that 5% 
acetic acid resulted in a decrease in activity in zebrafish and our study adds to this showing that the 
magnitude of the behavioral response scales with the concentration of acetic acid. These findings 
suggest that zebrafish detected the acetic acid as a nociceptive stimulus and responded to it with a 
change in behavior. Most studies using acetic acid in mammals inject the noxious stimulus IP and 
measure writhing. One study compared responses to various chemical noxious stimuli injected into the 
paw of the rat and showed that responses to acetic acid are similar to those to formalin [28]. In 
mammals the responses are flinching and licking the injected paw. In rats, these responses are marked 
during the first 10 min followed by a much less intense response for 20 to 65 min. The decrease in 
activity that we saw in zebrafish in the present experiment lasted throughout the 110 min recording 
period and we do not know how long it would have persisted. 
4.2. The Effect of Morphine in the Zebrafish Model of Nociception 
Considering that little is known about analgesics in fish [4], we tested the effect of two doses of 
morphine in our zebrafish nociceptive-based model. We observed that the administration of morphine 
sulphate, 30 min prior to giving the acetic acid noxious stimulus, attenuated the nociceptive-related 
behaviors of zebrafish in a dose-dependent manner. Previous studies using acetic acid as a noxious 
stimulus have reported the analgesic effect of morphine in fish but did not test the effect of dose 
[14,15,19] and in one case used an extraordinarily high dose of morphine (3,000 mg/kg, [27]). 
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Morphine at either 40 mg/kg or 50 mg/kg dose did not alter the acute response to a thermal noxious 
stimulus in goldfish, but seemed to counteract test-induced changes in behavior [29]. The doses used 
in our study are close to the range (1-10 mg/kg) commonly reported to elicit analgesic effects in 
mammals [30,31]. 
4.3. Modulation of Antinociceptive Behavior by Naloxone 
We also showed that pre-treatment with naloxone, an opioid receptor antagonist, significantly 
attenuated morphine antinociceptive behaviors in adult zebrafish. These results suggest an opioid 
receptor involvement in the morphine effect similar to mammals [32] and amphibians [33]. Two other 
studies using fish have reported that naloxone blocks analgesic effects of opioids [10,34]. In mammals, 
the analgesic effect of opioids is mediated mainly by mu-opioid receptors (MOR), a G-protein coupled 
receptor expressed in the CNS [35]. MOR homologues have been identified in several teleosts 
including in zebrafish and appear to be highly conserved in both the sequence and pharmacological 
properties [18,36,37,38,39]. 
4.4. Automated Analysis of the Nociceptive Behavioral Test in Zebrafish Model 
Another critical issue in establishing a model in nociception is the time required to assess the 
change in behavior in response to the noxious stimulus in the presence and absence of potential 
analgesics. Behavioral tests are complex and quantifying the behavioral response is time consuming 
and labor intensive. Automation in this field is crucial because it allows the experimenter to conduct 
several tests simultaneously. We used an electric biosensor (MOBS) to detect alterations in the 
locomotor activity in zebrafish before and after the noxious stimulus with and without analgesia. We 
hypothesized that this automated system would be less labor intensive compared with other systems 
(i.e., video tracking-system). The MOBS system has several advantages over a video tracking systems 
such as: i) no additional light sources are required minimizing the likelihood of interfering with the test 
organism; ii) the signal processing is controlled by external software and allows a flexible adaptation 
to changing testing conditions and iii) it is independent of the size of the test organism; juveniles as 
well as larger adults can be analyzed quantitatively at high speed. We showed that the baseline motor 
activity patterns of zebrafish can be accurately detected by the MOBS system because this species 
tends to swim with a series of bursts. Each burst is composed, from the signal detection point of view, 
of a sequence of strong tail-flips, at a rate of 2-5/s. This swimming pattern can be detected in the signal 
as a series of sharp edges where each edge associated with a tail flip. The detection of these sharp 
edges in the signal requires recovering a frequency spectrum of at least 20 Hz. Our software performs 
some pre-processing to perform automatic gain control and to adjust sharpness detection thresholds. 
Also, procedures are employed to detect and avoid a few situations of false positives that were 
identified when analyzing the signal shape. It was clear that both from visual inspection and statistical 
analysis that this measure strongly reflects the locomotion activity level of each fish. In earlier  
time-course studies we have produced visual ethograms describing the swimming behaviors of 
zebrafish and these recorded were compared with the signal output (i.e., shape of the waves over time 
when viewed on an oscilloscope) produced by MOBS in order to assure a correct identification of 
zebrafish swimming patterns. 
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To summarize, we showed that the locomotor response to a noxious chemical stimulus in zebrafish 
is a sensitive and robust model that can be used to evaluate analgesics - the response scaled with the 
intensity of the stimulus, it was attenuated by morphine in a dose dependent manner and naloxone 
blocked the analgesic effect of morphine. Furthermore, we confirmed the validity of this system by 
performing a similar experiment using a video tracking-system. In both situations the activity of fish 
decreased throughout the trial period after the noxious acetic acid stimulus. It demonstrated that the 
behavioral response of zebrafish to a noxious stimulus can be automated by MOBS. In the present 
experimental design we monitored four fish at the same time, but the present system could monitor up 
to 14 fish [11]. 
The MOBS system is capable of measuring other behavioral activity patterns such as fish 
ventilation [11]. However, ventilation could not be measured in the present experimental design 
because the chambers were too large relative to the size of the fish. One solution to this technical 
limitation would be using smaller test chambers, but this would confine the fish. 
We developed the model primary for qualitative screening purposes, but with an option for further 
quantitative dose response analysis (e.g., low dose analysis). The selected fish and dose numbers were 
too small to provide a more accurate dose-response pattern over time, but in principle we believe that 
this could be achieved with appropriate automation. The main bar for further proceeding is the  
time-consuming injection procedure, which was in all studies performed by one experimenter and thus 
the most limiting factor. A further impediment for routine testing is the current lack of appropriate 
statistical software that provides a quick and robust analysis of behavioral data. Traditional software 
packages are based on ANOVA methods with simple model assumptions that are often not fulfilled by 
behavior data. In our experience, the biggest problem are extreme data values (corresponding to high 
activity bursts within small time periods) that cannot be smoothed by common data transformation 
techniques, but require more robust statistical methods. We used a nonparametric approach to analyze 
the longitudinal data programmed in SAS, but to our knowledge no commercial software package is on 
the market that provides similar or alternative robust methods. This limits not only the analysis of 
existing dose-response data, but also the planning of necessary sample sizes for further studies. 
Preliminary results from simulation studies on our data suggest that at least 20 fish per treatment are 
required to achieve sufficient statistical power to detect at least 10% response differences between two 
treatments as statistically significant. This number corresponds to the minimal sample size of rodents 
used in many toxicological studies for testing chemicals on developmental and reproductive toxicity. 
5. Conclusions 
A change in behavioral responses of zebrafish to acetic acid is a reasonable model to test analgesics. 
The response scales with stimulus intensity, is attenuated by morphine in a dose-dependent manner, 
and the analgesic effect of morphine is blocked with naloxone. The change in behavior of zebrafish 
associated with the noxious stimulus can be monitored with an automated system that measures 
changes in impedance. 
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